Live feed
Filing
SC 13G/A
SC 13G/A0001535610-24-000015·SABBY MANAGEMENT, LLC
Schedule 13G ownership disclosure
BIONDVAX PHARMACEUTICALS LTD
Security class unavailable · CUSIP: 09073Q105
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 220,663
- Percent of class
- 5.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-24-000015
- Form type
- SC 13G/A
- Filer
- SABBY MANAGEMENT, LLC
- CIK
- CIK 1535610
- Filed
- Jan 02, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership